Atlas Trials

Study of Prognostic Biomarkers of Survival at 6 Months for Patients Treated With Bevacizumab Glioblastomas in First Relapse After Failure of Radiochemotherapy

Clinical trial NCT03144167 · RECRUITING

Trial details

NCT number
NCT03144167
Sponsor
Centre Hospitalier Universitaire, Amiens
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
GlioblastomaRadiotherapyChemotherapy
Start date
2019-06-18
Primary completion
2027-01-20
Enrollment
170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.